No abstract

No abstract

No funding was received for this work. Conflicts of interest: D. P. Mack has provided consultation and speaker services for Pfizer, Aimmune, Kaleo, Merck, Covis, and Pediapharm, and has been part of an advisory board for Pfizer and Bausch Health. He sits on the editorial board for the Journal of Food Allergy. M. A. Hanna has provided speaker services for Pfizer and Pediapharm. E. M. Abrams is a member of the health care advisory board for Food Allergy Canada; and is on the National Advisory Committee for Food Allergy Canada. T. Wong has provided speaking engagements for Pfizer and Stallergenes-Greer, and has been part of an advisory board for Leo Pharma. L. Soller participates in research with DBV Technologies. S. C. Erdle declares no relevant conflicts of interest. S. Jeimy has been on speaker's bureaus for Aralez, Astra Zeneca, Sanofi, and Novartis. J. L. P. Protudjer sits on the steering committee of the National Food Allergy Action Plan. E. S. Chan has received research support from DBV Technologies; has been a member of advisory boards for Pfizer, Pediapharm, Leo Pharma, Kaleo, and DBV; is a member of the health care advisory board for Food Allergy Canada; was co-lead of the CSACI oral immunotherapy guidelines; and was an expert panel and coordinating committee member of the National Institute of Allergy and Infectious Diseases (NIAID)sponsored Guidelines for Peanut Allergy Prevention.

No abstract